Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11332733 Modified compounds and uses thereof

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12110491 Selective reduction of allelic variants
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Eric E. Swayze0
Michael Oestergaard0
Michael T. Migawa0
Punit P. Seth0
Stanley T. Crooke0
Wen Shen0
Xue-hai Liang0
Edits on 17 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 19 May, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 May, 2022
Edits made to:
Infobox (+13 properties)
Article (+305 characters)
‌

 US Patent 11332733 Modified compounds and uses thereof

Article

The present disclosure provides oligomeric compound comprising a modified oligonucleotide having a central region comprising one or more modifications. In certain embodiments, the present disclosure provides oligomeric compounds having an improved therapeutic index or an increased maximum tolerated dose.

Infobox
Is a
Patent
Patent
Patent applicant
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11332733
Date of patent
May 17, 2022
Patent application number
16968701
Date Filed
February 12, 2019
Patent citations
‌
US Patent 11149264 Modified compounds and uses thereof
‌
US Patent 10017764 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
‌
US Patent 10202599 Selective antisense compounds and uses thereof
‌
US Patent 10415038 Compounds and methods for modulating TMPRSS6 expression
‌
US Patent 10426789 Allele specific modulators of P23H rhodopsin
Patent primary examiner
‌
Kimberly Chong

Find more entities like US Patent 11332733 Modified compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo